In addition, our results suggest that Bax is not involved in the apoptotic pathway (i.e. activation of caspase 3) but is nonetheless associated with cytotoxicity at concentrations that are likely to be reached during treatment of GBM patients. Here, CASP3 is linked to glioblastoma.